Neurocrine Biosciences
NBIX
#1457
Rank
S$15.96 B
Marketcap
$157.67
Share price
-4.42%
Change (1 day)
7.61%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$1.09 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are S$1.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$1.34 B51.95%
2022-12-31S$0.88 B-6.17%
2021-12-31S$0.94 B17.3%
2020-12-31S$0.80 B-10.76%
2019-12-31S$0.90 B28.87%
2018-12-31S$0.69 B17.49%
2017-12-31S$0.59 B719.89%
2016-12-31S$72.66 M2.07%
2015-12-31S$71.19 M56.93%
2014-12-31S$45.36 M4.5%
2013-12-31S$43.41 M-14.68%
2012-12-31S$50.88 M-49.81%
2011-12-31S$0.10 B-37.07%
2010-12-31S$0.16 B71.64%
2009-12-31S$93.87 M-19.37%
2008-12-31S$0.11 B-48.78%
2007-12-31S$0.22 B97.75%
2006-12-31S$0.11 B-25.78%
2005-12-31S$0.15 B-24.29%
2004-12-31S$0.20 B-26.51%
2003-12-31S$0.27 B279.38%
2002-12-31S$73.37 M10.23%
2001-12-31S$66.56 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.17 B 7.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.45 B 853.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$14.57 M-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$82.28 B 7,409.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$184.40 B 16,730.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$170.40 B 15,451.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.59 B-46.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$58.83 M-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA